Viropharma, Inc. (VPHM) Misses Q1 EPS by 5c; Guides FY12 Revs Below Views
Tweet
Share
E-mailGet Alerts VPHM Hot Sheet
Price: $49.96 --0%
Financial Fact:
Other income (expense), net: 3.53M
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Other income (expense), net: 3.53M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Viropharma, Inc. (NASDAQ: VPHM) reported Q1 EPS of $0.37, $0.05 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $135.8 million versus the consensus estimate of $149.16 million.
Sees FY2012 revenue of $450-$500 million, versus the consensus of $502.43 million.
For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.
Sees FY2012 revenue of $450-$500 million, versus the consensus of $502.43 million.
For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Northwest Bancshares, Inc. (NWBI) PT Lowered to $10 at Piper Sandler
- Philip Morris International (PM) Tops Q1 EPS by 9c; raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
